Clinical trial
Efficacy and Safety Study of Argatroban to Treat Heparin-Induced…
NCT00198588 · Ministry of Health, Labour and Welfare, Japan, Other · Completed
Key facts
| NCT number | NCT00198588 |
|---|---|
| Title | Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia |
| Official title | Open-Label Trial to Evaluate the Efficacy and Safety of the Use of Argatroban in Patients With Heparin-Induced Thrombocytopenia |
| Lead sponsor | Ministry of Health, Labour and Welfare, Japan, Other |
| Collaborators | Tanabe Pharma Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heparin-Induced Thrombocytopenia |
| Intervention type | Drug |
| Interventions | argatroban |
| Enrollment | 8 |
| Start date | Jun 1, 2005 |
| Primary completion | Jul 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Nov 13, 2008 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: